As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Shares of Aurora Cannabis Inc. ACB shed 1.40% to $6.33 Wednesday, on what proved to be an all-around mixed trading session ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...

Aurora Cannabis Inc. closed 29.30% below its 52-week high of $9.35, which the company reached on April 30th.

Driven primarily by its global medical cannabis division, which saw revenue surge 51% YoY to $68.1 million, the firm reported total net revenue of $88.2 million, a 37% year-over-year increase.

Consumer Cannabis Revenue: $9.9 million, down from $11.6 million last year. Aurora Cannabis Inc (NASDAQ:ACB) reported a record third quarter for medical cannabis revenue, net income, adjusted ...

Shares of Aurora Cannabis and other cannabis companies saw significant buying on Wednesday following Aurora’s quarterly earnings report. For its most recent quarter, Aurora reported total net ...

EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased ...

These achievements, along with our strong cash position and debt-free cannabis business, underscore Aurora’s leadership in the global cannabis industry as we continue to set ourselves apart from ...

A worker looks at cannabis seedlings at the new Aurora Cannabis facility Friday, November 24, 2017 in Montreal. (THE CANADIAN PRESS/Ryan Remiorz) · The Canadian Press Aurora Cannabis (ACB.TO)(ACB) ...